Eczema drug shows promise in repairing skin barrier
NCT ID NCT04447417
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 22 times
Summary
This study looked at how dupilumab, a medication for moderate to severe eczema, improves the skin's barrier function. Researchers measured water loss from the skin in 52 participants before and after treatment. The goal was to understand how well the drug helps restore the skin's natural protective layer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number 1240001
Montreal, H2X 2V1, Canada
-
Investigational Site Number 8400001
Denver, Colorado, 80206, United States
Conditions
Explore the condition pages connected to this study.